G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

World News: . []

RESEARCH TRIANGLE PARK NC May 16 2018 GLOBE NEWSWIRE) -- G1 Therapeutics Inc NasdaqGTHX a clinical-stage oncology company today announced that preliminary data from its Phase 1b2a clinical trial of G1T38 in combination with Faslodex (fulves...

More news and information about G1 Therapeutics

Published By:

Globe Newswire: 22:07 GMT Wednesday 16th May 2018

Published: .

Search for other references to "therapeutics" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us